News Website

Is Vaginal Estrogen Safe After Endometrial Cancer? - Medscape

Is Vaginal Estrogen Safe After Endometrial Cancer? Medscape

Published: March 4, 2026, 5:49 p.m.

Read Full Article

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds - News-Medical

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds News-Medical

Published: March 4, 2026, 2:18 p.m.

Read Full Article

Vaginal Estrogen Safe for Endometrial Cancer Survivors - Mirage News

Vaginal Estrogen Safe for Endometrial Cancer Survivors Mirage News

Published: March 4, 2026, 5:04 a.m.

Read Full Article

Howard Stern, Robin Quivers, Endometrial Cancer - SurvivorNet

Howard Stern, Robin Quivers, Endometrial Cancer SurvivorNet

Published: March 4, 2026, 2:56 a.m.

Read Full Article

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening Nature

Published: March 3, 2026, 10:36 a.m.

Read Full Article

6 Tips for Going Through Endometrial Cancer Treatment - Cleveland Clinic Health Essentials

6 Tips for Going Through Endometrial Cancer Treatment Cleveland Clinic Health Essentials

Published: March 3, 2026, 8:30 a.m.

Read Full Article

Engineering the Human Endometrial-Embryo Interface: Breakthroughs in 3D Uterine Models.

Three-dimensional (3D) organoid and co-culture models have emerged as transformative tools for studying human endometrial function, implantation, and placental development, overcoming key limitations of animal and two-dimensional in vitro systems. …

Published: March 3, 2026, midnight

Read Full Article

embryo implantation endometrial epithelial organoids endometrium placenta trophoblast organoids uterus

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Defense World

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Defense World

Published: March 2, 2026, 6:50 p.m.

Read Full Article

GLP-1–Progestin and Endometrial Cancer Risk - Conexiant

GLP-1–Progestin and Endometrial Cancer Risk Conexiant

Published: March 2, 2026, 5:01 p.m.

Read Full Article

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks

Published: Feb. 27, 2026, 7:47 p.m.

Read Full Article

Latest Articles

Is Vaginal Estrogen Safe After Endometrial Cancer? - Medscape

Vaginal estrogen therapy is safe for young endometrial cancer survivors, study finds - News-Medical

Vaginal Estrogen Safe for Endometrial Cancer Survivors - Mirage News

Howard Stern, Robin Quivers, Endometrial Cancer - SurvivorNet

Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening - Nature

6 Tips for Going Through Endometrial Cancer Treatment - Cleveland Clinic Health Essentials

Engineering the Human Endometrial-Embryo Interface: Breakthroughs in 3D Uterine Models.

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Defense World

GLP-1–Progestin and Endometrial Cancer Risk - Conexiant

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

Subscribe to Our Newsletter